Drug Screening Market: Global Trends, Top Players Updates, Future Plans, Industry Impact and Forecast till 2027

In the next years, rising alcohol consumption is expected to drive up need for drug screening. In 2016, India's alcohol consumption was anticipated to be around 5.4 billion litres, with the figure expected to rise to around 6.5 billion litres by 2020. The steady increase in consuming these beverages can be attributed to multiple factors including the rising levels of disposable income and a growing urban population, among others. ?

Furthermore, the increased alcoholic consumption among the younger age group has also been boosting the market drug screening market. According to the 2019 National Survey of Drug Use and Health, an estimated 414,000 adolescents aged 12 to 17 (1.7 percent of this age group) have AUD. There are 163,000 males (1.3 percent of males in this age range) and 251,000 females in this category (2.1% of females in this age group). Similarly, as per research, over 88% of Indians under the age of 25 purchase or drink alcoholic beverages, even though underage alcohol consumption is prohibited. Moreover, as per the Australia Institute of Health and Welfare, in 2018, young adults aged 18–24 were the most likely of all age groups to exceed single occasion risk guidelines at least monthly (41%), compared with 25% of people aged 14 and over, in Australia as well.

Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=7967

The COVID19 has resulted in a profound re-evaluation of the advantages and costs of Drug Screening. The COVID-19 pandemic has disrupted health systems worldwide. This has had a profound impact on drug screening tests. Due to limited or non-availability of medical facilities/treatment centers, harm reduction service providers, and the fear of infection transmission, it has caused significant disruptions to businesses and economic activities around the world, and it is expected to have a short-term negative impact on the drug screening market. A recent survey performed by the Current Consulting Group (CCG) in 2021, found that since the start of the pandemic, 21% of employers have reported a drop of 61% or more in the number of drug tests that they perform on employees in the US states. However, government associations have been working on increasing adoption for fingerprint drug screening because of its multiple advantages such as efficiency, non-invasiveness, low cost, accuracy, and hygienic. For instance, Intelligent Fingerprinting launched fingerprint drug screening kits and devices such as Intelligent Fingerprinting DSR-Plus, Intelligent Fingerprinting Drug Screening Cartridges; etc. ?

According to UnivDatos Market Insights (UMI)’ research report “Global Drug Screening Market Analysis, 2020”, the Global Drug Screening market is projected to grow at a CAGR of XX% during 2021-27F. The rise in overuse of prescribed drugs, increase in the use of narcotics and illicit drugs has resulted in an upsurge in drug screening usage around the world. For instance, according to the Our World in Data, Illicit drug use is, directly and indirectly, responsible for over 750,000 deaths per year. Illicit drug use is responsible for 585,000 premature deaths by increasing the risk of disease and injury. ?

Based on the product and services, drug screening products grabbed XX% revenue share in 2020. The market size of this segment touched US$ XX Billion in 2020. The market share of the segment is expected to maintain its dominance in the forthcoming years as well owing to the increased applications of rapid testing devices such as urine testing devices and oral fluid testing devices.

Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=7967 ?

Drug screening products to Witness Robust growth

Based on the Sample, the urine samples segment acquired the major market share and grabbed US$ XX Billion revenues from the Drug Screening market in 2020. Benefits it offers such as high accuracy in the detection of multiple drugs, cost-effectiveness, and instant results is boosting the growth.

Urine samples to Witness Robust growth

Based on the End-Users, the workplace segment acquired the major market share and grabbed US$ XX Billion in revenues from the Drug Screening market in 2020. Growing safety concerns in the workplace and the increasing number of organizations that have made regular drug screening mandatory are boosting the growth.

Workplace drug screening to Witness Robust growth?

North America to Grab Lion’s Share, Bit Europe to witness Explicit Growth

Based on the Region, North America dominated the Global Drug Screening market in 2020. The region is projected to maintain its dominance during the forecasted period 2021-27 owing to the presence of laws supporting drug screening has been boosting the demand for Drug Screening. However, Asia is expected to register the highest CAGR during the forecast period owing to the growing burden of accidents due to unsafe levels of alcohol consumption.

According to UnivDatos Market Siemens, Thermo Fisher, LabCorp, Alere, Omega Laboratories, Roche, OraSure, Biomedical Diagnostics, Quest Diagnostics, Laboratory Corporation of America Holdings among others. The players are focused on launching new products for gaining customers' traction and expanding their geographical reach to get a competitive edge in the industry. Some of the instances are:

·???????In 2020, LabCorp signed a multi-year arrangement with Infirmary Health (US) to provide laboratory testing services along the Gulf Coast's eastern shore

·???????In 2020, Psychemedics launched a vaping panel test that identifies marijuana, CBD, and nicotine drug intake through any means, including electronic cigarettes or smoking

·???????In February 2019, Boston Clinical Laboratories' clinical laboratory services business was bought by Quest Diagnostics. Patients and physicians at BCL were able to use Quest services because of this

“Global Drug Screening Market Analysis , 2020” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for Drug Screening providers across the Globe. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitor's capabilities on 16 parameters. This will help companies in the formulation of Go to Market Strategies and identifying the blue ocean for its offerings.????

For more informative information, please visit us – https://univdatos.com/report/drug-screening-market/ ?

Market Segmentation:

1.????By Product and Services (Drug Screening Products And Drug Screening Services)

2.????By Sample (Urine Samples, Oral Fluid Samples, Breath Samples, Hair Samples, And Other Samples)

3.????By End-Users (Workplaces, Drug Testing Laboratories, Criminal Justice Systems & Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, And Schools & Colleges)

4.????By Region (North America, Europe, Asia-Pacific, Rest of the World)

5.????By Company (Siemens, Thermo Fisher, LabCorp, Alere, Omega Laboratories, Roche, OraSure, Biomedical Diagnostics, Quest Diagnostics, Laboratory Corporation of America Holdings, etc.)

Key questions answered in the study:

1.?????What are the current and future trends of the Global Drug Screening industry?

2.?????How the industry has been evolving in terms of technology and application areas?

3.?????How the competition has been shaping across the countries followed by their comparative factorial indexing?

4.?????What are the key growth drivers and challenges for the Drug Screening industry?

5.?????What is the customer orientation, purchase behavior, and expectations from the Drug Screening firms across various regions??